The Office of Biological Safety facilitates the Committee on Microbiological Safety (COMS). COMS is a standing faculty committee that reviews all research involving recombinant DNA as well as work involving biohazards at Harvard and its 16 affiliated institutions. The Office provides the administrative support for the Committee and the technical review of COMS applications. The Office also supports the biosafety programs at these institutions by providing additional risk assessment as well as establishing policies and procedures.
On Friday, December 13, 2013 at noon the Harvard Institutional Biosafety Committee will open a regularly scheduled meeting at the Harvard Medical School to the general public. The public will be able to the view how the committee deals with biological research at institutions in the Longwood Medical Area. Questions from the public will be encouraged. This annual open meeting is required by the Boston Public Health Commission’s Biological Laboratory regulation.
For further information and to RSVP, please call 617.432.4897 or email COMS@hms.harvard.edu.
***COMS has revised our registration and amendment forms to include sections for Synthetic Nucleic Acid Molecules. Please use these forms for any new registrations or amendments.
***The COMS Policy Manual has been updated to include Synthetic Nucleic Acid Molecules.
***COMS has created a frequently asked questions document regarding Synthetic Nucleic Acid Molecules.
The latest version of the NIH Guidelines can be found here.